Reditux 100 mg is the trade name of a biosimilar version of rituximab, an anti-CD20 antibody used in the treatment of certain lymphomas, leukaemias and rheumatoid arthritis. Reditux is produced by Dr. Reddy's Laboratories, India's largest pharmaceutical company. It is a replacement for Mabthera ( Also known as Ristova in India )
- Minimum Order Quantity: 1 Piece/Pieces
- Port of Dispatch: Mumbai
- Production Capacity: 1000-1500
- Delivery Time: 7-10 days
- Packaging Details: High quality packaging and storage facilities are used to store products.